| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | Apr 8, 2025 | Compass Therapeutics, Inc. | CHIEF ACCOUNTING OFFICER | Buy | 86.3 | +20,000 | 6.67% | ✗ | $28.4K |
| May 4, 2020 | May 6, 2020 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -399 | -2.45% | ✗ | $2.3K |
| May 3, 2019 | May 7, 2019 | PSYCHEMEDICS CORP | VP - Finance | Sell | 90.0 | +3,346 | 25.90% | ✗ | $1.6K |
| Apr 30, 2019 | May 2, 2019 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -301 | -2.28% | ✗ | $3.5K |
| Mar 11, 2019 | Mar 13, 2019 | PSYCHEMEDICS CORP | VP - Finance | Sell | 22.5 | -9,057 | -40.66% | ✗ | $136.8K |
| May 21, 2018 | May 23, 2018 | PSYCHEMEDICS CORP | VP - Finance | Sell | 22.5 | -4,892 | -18.01% | ✗ | $98.2K |
| May 8, 2018 | May 10, 2018 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -282 | -1.03% | ✗ | $5.7K |
| Apr 30, 2018 | May 2, 2018 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -286 | -1.11% | ✗ | $6K |
| May 23, 2017 | May 25, 2017 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -276 | -1.07% | ✗ | $5.8K |
| May 8, 2017 | May 9, 2017 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -284 | -1.10% | ✗ | $5.9K |
| May 1, 2017 | May 3, 2017 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -311 | -1.21% | ✗ | $5.8K |
| Nov 18, 2016 | Nov 21, 2016 | PSYCHEMEDICS CORP | VP - Finance | Sell | 22.5 | -3,000 | -10.44% | ✗ | $74.3K |
| May 23, 2016 | May 24, 2016 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -707 | -2.40% | ✗ | $9.4K |
| May 8, 2016 | May 11, 2016 | PSYCHEMEDICS CORP | VP - Finance | Sell | 37.5 | -295 | -0.99% | ✗ | $4.1K |
| May 2, 2016 | May 2, 2016 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -327 | -1.09% | ✗ | $4.7K |
| Sep 10, 2015 | Sep 14, 2015 | PSYCHEMEDICS CORP | VP - Finance | Buy | 91.3 | +3,000 | 11.09% | ✗ | $31K |
| May 22, 2015 | May 27, 2015 | PSYCHEMEDICS CORP | VP - Finance | Sell | 26.3 | -1,051 | -1.32% | ✗ | $15.4K |
| May 8, 2015 | May 11, 2015 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -311 | -1.10% | ✗ | $4.7K |
| May 28, 2013 | May 29, 2013 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -824 | -3.71% | ✗ | $9.4K |
| Jun 15, 2012 | Jun 19, 2012 | PSYCHEMEDICS CORP | VP - Finance | Buy | 91.3 | +2,500 | 15.44% | ✗ | $24.5K |
| May 24, 2012 | May 29, 2012 | PSYCHEMEDICS CORP | VP - Finance | Sell | 27.5 | -400 | -2.41% | ✗ | $3.9K |
| May 24, 2011 | May 26, 2011 | PSYCHEMEDICS CORP | VP - Finance | Buy | 95.0 | +10,595 | 529.75% | ✗ | $59K |
| Mar 17, 2011 | Mar 21, 2011 | PSYCHEMEDICS CORP | President | Buy | 91.3 | +2,000 | 100.00% | ✗ | $18.2K |